Safe Fertility Group PCL (BKK:SAFE)
5.55
0.00 (0.00%)
At close: Jul 24, 2026
Safe Fertility Group PCL Financials Overview
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 700.21 | 701.92 | 830.13 | 848.64 | 726.61 | 559.73 |
Revenue Growth | -7.23% | -15.45% | -2.18% | 16.79% | 29.82% | 6.52% |
Gross Profit Gross Profit Growth | 390.38 | 391.2 | 457.28 | 469.09 | 397.45 | 274.54 |
Operating Income Operating Income Growth | 149.21 | 146.95 | 203.1 | 242.44 | 203.7 | 101.03 |
Net Income Net Income Growth | 132.95 | 131.1 | 167.09 | 201.83 | 161.91 | 78.23 |
Earnings Per Share EPS Growth | 0.44 | 0.43 | 0.55 | 0.77 | 0.72 | 0.35 |
EPS Growth | 0.35% | -21.54% | -28.46% | 6.78% | 106.96% | 85.59% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Obstetrics and Gynecology Hospital Business Specialties and Medical Laboratories Obstetrics and Gynecology Hospital Business Specialties and Medical Laboratories Growth | 686.65 | 683.93 | 811.43 | 842.8 | 726.61 |
Cosmetic Dermatology Cosmetic Dermatology Growth | 13.57 | 17.99 | 18.7 | 5.84 | - |
Total Total Growth | 700.21 | 701.92 | 830.13 | 848.64 | 726.61 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,661 | 1,605 | 1,628 | 1,483 | 1,079 | 971.07 |
Total Debt Total Debt Growth | 57.55 | 61.12 | 75.05 | 93.84 | 86.33 | 94.27 |
Net Cash (Debt) Net Cash Growth | 1,603 | 1,543 | 1,553 | 1,389 | 992.81 | 876.8 |
Net Cash Growth | 0.11% | -0.63% | 11.82% | 39.91% | 13.23% | 9.14% |
Net Cash Per Share Net Cash Per Share Growth | 5.27 | 5.08 | 5.11 | 5.29 | 4.41 | 3.90 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 183.03 | 170.59 | 239.9 | 252.76 | 211.36 | 171.82 |
Capital Expenditures CapEx Growth | -4.66 | -3.97 | -45.89 | -32.93 | -33.82 | -13.46 |
Free Cash Flow Free Cash Flow Growth | 178.36 | 166.62 | 194.01 | 219.83 | 177.54 | 158.36 |
Free Cash Flow Growth | 20.29% | -14.12% | -11.75% | 23.82% | 12.11% | 158.73% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 55.75% | 55.73% | 55.08% | 55.27% | 54.70% | 49.05% |
Operating Margin | 21.31% | 20.94% | 24.46% | 28.57% | 28.03% | 18.05% |
Pretax Margin | 23.46% | 23.10% | 25.73% | 29.14% | 27.94% | 17.61% |
Profit Margin | 18.99% | 18.68% | 20.13% | 23.78% | 22.28% | 13.98% |
FCF Margin | 25.47% | 23.74% | 23.37% | 25.90% | 24.43% | 28.29% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.410 | 0.410 | 0.620 | 0.150 | 2.900 | 0.248 |
Dividend Per Share Growth | -33.87% | -33.87% | 313.33% | -94.83% | 1069.36% | -15.65% |
Dividend Yield | 7.39% | 6.91% | 5.46% | 0.95% | - | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.69 | 14.72 | 23.65 | 27.56 | - | - |
Forward PE | 11.18 | 14.05 | 20.59 | 20.94 | - | - |
P/FCF Ratio | 9.46 | 11.58 | 20.37 | 25.30 | - | - |
PS Ratio | 2.41 | 2.75 | 4.76 | 6.55 | - | - |